Postoperative recurrence of epithelial ovarian cancer patients and chemoresistance related protein analyses-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Postoperative recurrence of epithelial ovarian cancer patients and chemoresistance related protein analyses

Published:2019-03-27 Issue:1 Volume:12 Page:
ISSN:1757-2215
Container-title:Journal of Ovarian Research
language:en
Short-container-title:J Ovarian Res

Author:

Zhang Zhengmao,Qin Kaiyun,Zhang Wenzhe,Yang Botao,Zhao Chen,Zhang Xiaojing,Zhang Fenghua,Zhao Lianmei,Shan Baoen

Funder

Hebei Natural Science Foundation

Capital Marathon Foundation of Chinese Cancer Association

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynecology,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13048-019-0499-z.pdf

Reference24 articles.

1. Sood AK, Buller RE. Drug resistance in ovarian cancer: from the laboratory to the clinic. Obstet Gynecol. 1998;92(2):312–9.

2. Fung-Kee-Fung M, Oliver T, Elit L, Oza A, Hirte HW, Bryson P. Optimal chemotherapy treatment for women with recurrent ovarian cancer. Curr Oncol. 2007;14(5):195–208.

3. Bear HD, Anderson S, Smith RE, Geyer CE Jr, Mamounas EP, Fisher B, et al. Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and bowel project protocol B-27. J Clin Oncol. 2006;24(13):2019–27. https://doi.org/10.1200/JCO.2005.04.1665 .

4. Broxterman HJ, Gotink KJ, Verheul HM. Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib. Drug Resist Updat. 2009;12(4–5):114–26. https://doi.org/10.1016/j.drup.2009.07.001 .

5. Kozak KR, Su F, Whitelegge JP, Faull K, Reddy S, Farias-Eisner R. Characterization of serum biomarkers for detection of early stage ovarian cancer. Proteomics. 2005;5(17):4589–96. https://doi.org/10.1002/pmic.200500093 .

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIST1H2BK predicts neoadjuvant-chemotherapy response and mediates 5-fluorouracil resistance of gastric cancer cells;Translational Oncology;2024-08

2. Scientific and clinical relevance of non-cellular tumor microenvironment components in ovarian cancer chemotherapy resistance;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-01

3. Prediction of Chemoresistance—How Preclinical Data Could Help to Modify Therapeutic Strategy in High-Grade Serous Ovarian Cancer;Current Oncology;2023-12-29

4. Clusterin and Its Isoforms in Oral Squamous Cell Carcinoma and Their Potential as Biomarkers: A Comprehensive Review;Biomedicines;2023-05-16

5. Apolipoproteins: New players in cancers;Frontiers in Pharmacology;2022-11-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3